Navigation For Mobile
  2. >
  3. Blog
  4. >
  5. drug delivery

Category Archives: drug delivery

Beyond COVID-19: What Else in Happening in Pharma?

Posted on July 17, 2020 by

Around the world, pharma and biopharma – along with all of the supporting industries, from suppliers and research organizations to outsourced providers – have been exclusively focused on COVID-19. With…

Posted in APIs, drug delivery, drugs, peptide, peptides | Tagged , , , | Comments Off on Beyond COVID-19: What Else in Happening in Pharma?

The Promise of Peptides: Developments in 3 Key Areas Reawaken Therapeutic Potential

Posted on March 6, 2016 by

In a post last month, we discussed the three types of peptide production techniques Neuland uses to cGMP manufacture peptide APIs and NCEs for clients. We also mentioned some of the…

Posted in APIs, Chemistry, CMC, Contract Manufacturing, drug delivery, drugs, Fmoc, Neuland Labs, peptide, Peptide aggregation, peptides, process chemistry, synthesis, Synthesis Route | Comments Off on The Promise of Peptides: Developments in 3 Key Areas Reawaken Therapeutic Potential

Peptide Process Chemistry – A New Era?

Posted on April 2, 2015 by

Since pioneers such as Bodanszky and Du Vigneaud first produced them synthetically in the 1950’s, peptides have always held tremendous – but unrealized – promise for human health. Despite their…

Posted in APIs, Capabilities, cardiovascular disease, Contract Manufacturing, drug delivery, genotoxic impurities, Neuland Labs, oncology, peptide, peptides, R&D, scale-up, transdermal | Comments Off on Peptide Process Chemistry – A New Era?

API Micronization & Nanosizing: Mastering Particle Size

Posted on June 2, 2014 by

Micronizing – and particularly nanosizing – active pharmaceutical ingredients (APIs) has become an integral part of the drug development & manufacturing process. And with a variety of techniques available to…

Posted in APIs, Chemistry, CMC, drug delivery, R&D, scale-up | Comments Off on API Micronization & Nanosizing: Mastering Particle Size

Therapeutic Peptides – Has This Emerging Market Grown Up?

Posted on April 22, 2013 by

Yes – The Peptide Drug Market Has Come of Age. Peptide drugs are not a new phenomenon by any stretch of the imagination. The first approved peptide-based drug – insulin…

Posted in APIs, Congtract Manufacturing, drug delivery, peptides | Comments Off on Therapeutic Peptides – Has This Emerging Market Grown Up?